Hosted on MSN
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals RXRX shares have gained 5.5% in a month. The stock gained momentum after the company announced the acquisition of Rallybio’s full stake in their joint venture earlier this ...
GCD's A-graders turned up the heat in this week's competition, including four 180s from Tahuna Irwin, three to Kayne Arahanga and a 158 finish by Sean Gooch. 180s: Derek Creswell 2, John Downs, Leroy ...
Buying pharmaceutical stocks gives investors exposure to the global pharmaceutical market. This market totals roughly $2 trillion and continues to grow. The huge sector improves the quality of life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results